WO2005016253A3 - Formula nd method for the delivery of oral medications to animals - Google Patents

Formula nd method for the delivery of oral medications to animals Download PDF

Info

Publication number
WO2005016253A3
WO2005016253A3 PCT/US2004/022851 US2004022851W WO2005016253A3 WO 2005016253 A3 WO2005016253 A3 WO 2005016253A3 US 2004022851 W US2004022851 W US 2004022851W WO 2005016253 A3 WO2005016253 A3 WO 2005016253A3
Authority
WO
WIPO (PCT)
Prior art keywords
compound
medication
supplement
animals
delivery
Prior art date
Application number
PCT/US2004/022851
Other languages
French (fr)
Other versions
WO2005016253A2 (en
Inventor
Lawrence J Putz
Original Assignee
Petworks Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Petworks Llc filed Critical Petworks Llc
Priority to US10/565,095 priority Critical patent/US20060246116A1/en
Priority to GB0603229A priority patent/GB2421892B/en
Publication of WO2005016253A2 publication Critical patent/WO2005016253A2/en
Publication of WO2005016253A3 publication Critical patent/WO2005016253A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Abstract

A compound is used to conceal a medication or supplement to be given to an animal. The compound includes water as a carrier solvent, at least one hydrogenated oil, at least one emulsifier and a preservative. One or more additional ingredients may also be optionally added to the compound. These ingredients include anti-caking agents, viscosifiers, flavorings, coloring agents and binders. In any event, the embodiments may have a peel strength to paper of about 0.079 lbs./inch or a peel strength to itself of about 0.079 lbs./inch. It may have a tensile strength of about 0.33 psi and a compressive strength of about 2.02 psi. The invention also includes a method of administering a medication/supplement to an animal by forming a layer of the compound around the medication/supplement.
PCT/US2004/022851 2003-07-18 2004-07-14 Formula nd method for the delivery of oral medications to animals WO2005016253A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/565,095 US20060246116A1 (en) 2003-07-18 2004-07-14 Formula and method for the delivery of medications to animals
GB0603229A GB2421892B (en) 2003-07-18 2004-07-14 Formula and method for the delivery of oral medications to animals

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48859203P 2003-07-18 2003-07-18
US60/488,592 2003-07-18

Publications (2)

Publication Number Publication Date
WO2005016253A2 WO2005016253A2 (en) 2005-02-24
WO2005016253A3 true WO2005016253A3 (en) 2005-04-14

Family

ID=34193076

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/022851 WO2005016253A2 (en) 2003-07-18 2004-07-14 Formula nd method for the delivery of oral medications to animals

Country Status (2)

Country Link
GB (1) GB2421892B (en)
WO (1) WO2005016253A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110777101A (en) * 2019-12-02 2020-02-11 湖南海珊水产养殖有限公司 Method for cultivating biological flocs for cultivating penaeus vannamei boone

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629394A (en) * 1969-10-13 1971-12-21 William E Gaunt Pleasant tasting chewable tablets and their production
US4752485A (en) * 1984-10-05 1988-06-21 Warner-Lambert Company Novel sweetener delivery systems
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
JPH0791186B2 (en) * 1987-06-25 1995-10-04 川崎化成工業株式会社 L-ascorbic acid preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Also Published As

Publication number Publication date
WO2005016253A2 (en) 2005-02-24
GB2421892B (en) 2007-02-14
GB2421892A (en) 2006-07-12
GB0603229D0 (en) 2006-03-29

Similar Documents

Publication Publication Date Title
WO2004060405A3 (en) Tissue reactive compounds and compositions and uses thereof
WO2004017920A3 (en) Novel biphenyl and biphenyl-like cannabinoids
WO2006044362A3 (en) N-sulfonylpiperidine cannabinoid receptor 1 antagonists
EP1987821A3 (en) Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
CA2534199A1 (en) Edible films for administration of medicaments to animals
WO2003000343A3 (en) Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
WO2004071529A3 (en) Uses of anti-insulin-like growth factor i receptor antibodies
WO2008001200A3 (en) Transdermal composition having enhanced color stability
WO2004010941A3 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
WO2003020024A3 (en) Treatment and prevention of infections in plants
HK1096399A1 (en) P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same p-
DE69213010T2 (en) Use of a bacteriocin antibiotic agent in the manufacture of a medicament for the treatment of upset stomach caused by Helicobacter pylori.
MXPA02002249A (en) Palatable pharmaceutical compositions for companion animals.
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
WO2004064806A3 (en) Process for modifying drug crystal formation
WO2007016352A3 (en) Oral liquid losartan compositions
DE59510042D1 (en) 2,2-DICHLORAL CARCONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF MEDICINAL PRODUCTS, AND THEIR USE FOR TREATING INSULIN RESISTANCE
WO2005112967A3 (en) Anticancer activity of chios mastic gum
EP1632226A4 (en) Anti-inflammatory analgesic adhesive patch
RS106704A (en) Stabilised pharmaceutical compositions on the basis of polyoxyethylated castor oil and method for manufacturing the same
MA28862B1 (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF A GASTRIC RESISTANCE COMPRESSOR CONTAINING AN ACTIVE INGREDIENT
MXPA05013270A (en) Transmucosal form of administration with reduced mucosal irritation.
WO2003092655A3 (en) Use of active ingredient mixtures with azelaic acids and glycyrrhetic acids as anti-acne agents
WO2004039326A3 (en) Propofol with cysteine
BR0011174A (en) Compositions, compounds, isolated compounds and methods to control pests

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 0603229

Country of ref document: GB

WWE Wipo information: entry into national phase

Ref document number: 2006246116

Country of ref document: US

Ref document number: 10565095

Country of ref document: US

122 Ep: pct application non-entry in european phase
WWP Wipo information: published in national office

Ref document number: 10565095

Country of ref document: US